These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8297107)

  • 1. The interactions of protein inhibitors with tumour proteases studied in solution and immobilised on cell surfaces in frozen sections.
    Steven FS; Anees M; Talbot IC; Blakey DC; Hasleton PS
    Anticancer Res; 1993; 13(6A):2003-10. PubMed ID: 8297107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association and dissociation of a protease and its inhibitor on the surface of lung squamous cell carcinoma cells.
    Steven FS; Anees M; Myers J; Hasleton P
    Anticancer Res; 1993; 13(4):1063-8. PubMed ID: 8352526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selectivity of the plasminogen activator inhibitor (PAI-1) for the iso enzyme of guanidinobenzoatase on the surface of colonic carcinoma cells.
    Steven FS; Anees M; Booth NA
    Anticancer Res; 1995; 15(1):205-10. PubMed ID: 7733635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further evidence for different isoenzymic forms of a cell surface protease, guanidinobenzoatase, associated with tumours.
    Steven FS; Griffin MM; Blakey DC; Talbot IC; Hanski C; Bell J
    Anticancer Res; 1992; 12(6B):2159-64. PubMed ID: 1295463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the functional similarity between tumour cell surface guanidinobenzoatase and tissue type plasminogen activator.
    Steven FS; Griffin MM; Cederholm-Williams SA; Mangel WF; Maier H
    Anticancer Res; 1991; 11(2):641-7. PubMed ID: 1905903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the interaction and exchange of inhibitors and proteases on the surface of tumour cells in frozen sections.
    Steven FS; Griffin MM; Bulleid NJ; Maier H; Born IA
    Anticancer Res; 1991; 11(6):2117-22. PubMed ID: 1776849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for distinct isoenzymic forms of a cell surface protease on normal colonic cells and on carcinoma cells from the same colon.
    Steven FS; Griffin MM; Talbot IC
    Anticancer Res; 1991; 11(1):143-50. PubMed ID: 1708219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential competitive inhibition of a cell surface protease on normal epithelial cells and carcinoma cells of the colon.
    Steven FS; Anees M; Talbot IC
    Anticancer Res; 1994; 14(5A):2013-6. PubMed ID: 7847843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinity preparation of a protein inhibitor recognising a cell surface protease.
    Steven FS; Griffin MM; Bell J; Talbot IC
    J Enzyme Inhib; 1993; 7(1):65-76. PubMed ID: 7510796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The targeting of agmatine-liganded mitomycin C to an enzyme on the surface of tumour cells.
    Steven FS; Griffin MM; Talbot IC
    Anticancer Res; 1990; 10(3):583-9. PubMed ID: 2114817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Location of tumour cells in colon tissue by Texas red labelled pentosan polysulphate, an inhibitor of a cell surface protease.
    Anees M
    J Enzyme Inhib; 1996; 10(3):203-14. PubMed ID: 8835946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple fluorescent technique for the location of tumour cells in frozen sections of the head and neck region.
    Steven FS; Griffin MM; Maier H; Born A; Zoeller J
    Anticancer Res; 1991; 11(3):1189-94. PubMed ID: 1716085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of fibrin fibrils in the dissociation of a cell surface protease-inhibitor complex and evidence for the recapture of the inhibitor protein.
    Steven FS; Blakey DC
    J Enzyme Inhib; 1992; 5(4):299-315. PubMed ID: 1285251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting adriamycin to tumour cells by means of an affinity ligand; a model system for drug delivery.
    Steven FS; Griffin MM; Williams LA; Ali H; Maier H
    Anticancer Res; 1989; 9(1):247-53. PubMed ID: 2705751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of a tumour protease with 3,4-dichloroisocoumarin, pentamidine-isethionate and guanidino derivatives.
    Anees M; Steven FS
    J Enzyme Inhib; 1994; 8(3):213-21. PubMed ID: 7539490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid inhibition of a tumour protease immobilised on cell surfaces and in free solution.
    Anees M; Steven FS
    J Enzyme Inhib; 1994; 8(1):51-9. PubMed ID: 7539069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibitor reacting with a tumour cell surface protease can be exchanged with plasminogen activator inhibitor (PAI-1).
    Steven FS; Booth NA
    J Enzyme Inhib; 1991; 4(3):273-9. PubMed ID: 2037870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of tissue plasminogen activator inhibitor with cell surface guanidinobenzoatase and urokinase plasminogen activator.
    Anees M
    J Enzyme Inhib; 1996; 10(4):281-8. PubMed ID: 8872748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fluorescent study of ligands for guanidinobenzoatase, a protease associated with tumour cells.
    Steven F; Griffin MM; Williams LA; Feichter G
    Anticancer Res; 1988; 8(6):1179-83. PubMed ID: 3218954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GB (guanidinobenzoatase) cell surface protease and serum inhibitors in colorectal neoplasia.
    Steven FS; Griffin MM; Talbot IC
    J Pathol; 1992 May; 167(1):19-24. PubMed ID: 1625054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.